Haemonetics | HAE - Assets


Haemonetics reported $2.37B in Assets for its fiscal quarter ending in June of 2026.





Assets Change Date
Baxter International USD 19.41B 377M Sep/2026
Becton, Dickinson and Co. USD 50.73B 101M Jun/2026
Boston Scientific USD 45.22B 865M Jun/2026
Cerus USD 221.86M 6.67M Dec/2025
Cooper Companies USD 12.67B 191.1M Jun/2026
Fresenius EUR 41.84B 526M Jun/2026
Fresenius Medical Care EUR 31.29B 174.35M Jun/2026
Globus Medical USD 5.49B 48.7M Jun/2026
Haemonetics USD 2.37B 30.52M Jun/2026
ICU Medical USD 3.97B 42.48M Jun/2026
Intuitive Surgical USD 19.35B 1.53B Sep/2026
Medtronic USD 93.31B 278M Jun/2026
Merit Medical Systems USD 2.92B 61.29M Sep/2026
Neogen USD 3.3B 42.8M Jun/2026
OraSure Technologies USD 360.55M 18.62M Jun/2026
Plus Therapeutics USD 14.03M 5.89M Jun/2026
Quidel USD 5.72B 86.6M Jun/2026
ResMed USD 8.21B 754.14M Sep/2026
STAAR Surgical USD 475.2M 24.09M Jun/2026
Steris USD 10.74B 1.1M Jun/2026
Stryker USD 47.25B 683M Sep/2026
Teleflex USD 6.79B 3.78M Jun/2026
Terumo JPY 2.37T 61.86B Jun/2026
Thermo Fisher Scientific USD 114.23B 1.06B Sep/2026
US Physical Therapy USD 1.25B 6.82M Jun/2026
Zimmer Biomet Holdings USD 22.8B 76.2M Jun/2026